期刊
SMALL
卷 12, 期 45, 页码 6266-6278出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/smll.201601868
关键词
-
类别
资金
- National Research Foundation of Korea [NRF-2015R1A2A1A15053771, 2016M3C9A4921712]
- Translational Research Center for Protein Function Control - Ministry of Science, ICT and Future Planning, Republic of Korea [TRCP 2016R1A5A1004694]
- Korea Health Technology R&D Project - Ministry of Health and Welfare, Republic of Korea [HI13C1479]
- National Research Foundation of Korea [2016R1A5A1004694, 2013H1A8A1004238, 2016M3C9A4921712, 22A20130011095, 2015R1A2A1A15053771] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
Using small interfering RNA (siRNA) to regulate gene expression is an emerging strategy for stem cell manipulation to improve stem cell therapy. However, conventional methods of siRNA delivery into stem cells based on solution-mediated transfection are limited due to low transfection efficiency and insufficient duration of cell-siRNA contact during lengthy culturing protocols. To overcome these limitations, a bio-inspired polymer-mediated reverse transfection system is developed consisting of implantable poly(lactic-co-glycolic acid) (PLGA) scaffolds functionalized with siRNA-lipidoid nanoparticle (sLNP) complexes via polydopamine (pDA) coating. Immobilized sLNP complexes are stably maintained without any loss of siRNA on the pDA-coated scaffolds for 2 weeks, likely due to the formation of strong covalent bonds between amine groups of sLNP and catechol group of pDA. siRNA reverse transfection with the pDA-sLNP-PLGA system does not exhibit cytotoxicity and induces efficient silencing of an osteogenesis inhibitor gene in human adipose-derived stem cells (hADSCs), resulting in enhanced osteogenic differentiation of hADSCs. Finally, hADSCs osteogenically committed on the pDA-sLNP-PLGA scaffolds enhanced bone formation in a mouse model of critical-sized bone defect. Therefore, the bio-inspired reverse transfection system can provide an all-in-one platform for genetic modification, differentiation, and transplantation of stem cells, simultaneously enabling both stem cell manipulation and tissue engineering.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据